Virpax Appoints Vinay Shah To Serve As CFO, Effective June 20, 2023, As Christopher Chipman Resigns
Portfolio Pulse from Benzinga Newsdesk
Virpax Pharmaceuticals has appointed Vinay Shah as its new CFO, effective June 20, 2023, following the resignation of Christopher Chipman. Chipman will remain with the company until June 30, 2023, to ensure a smooth transition.
June 20, 2023 | 8:13 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Virpax Pharmaceuticals (VRPX) appoints Vinay Shah as CFO, effective June 20, 2023, following Christopher Chipman's resignation.
The appointment of a new CFO is an important event for a company, but it is not expected to have a significant short-term impact on the stock price. The smooth transition period with Chipman remaining until June 30, 2023, should help maintain stability.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100